Compound Summary


loxapine
  Compound Information
 loxapine

Compound Name:

loxapine

Compound CID:

3964

Synonyms:

loxapine

Cloxazepine

Oxilapine

1977-10-2

Loxitane

More...

Iupac Name:

8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine

InChI:

InChI=1S/C18H18ClN3O/c1-21-8-10-22(11-9-21)18-14-12-13(19)6-7-16(14)23-17-5-3-2-4-15(17)20-18/h2-7,12H,8-11H2,1H3

InChIKey:

XJGVXQDUIWGIRW-UHFFFAOYSA-N

Canonical Smiles:

CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl

Isomeric Smiles:

CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl

Molecular Weight:

327.8

Molecular Formula:

C18H18ClN3O

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 loxapine

Molecular Weight:

327.8

Molecular Formula:

C18H18ClN3O

Hydrogen Bond Donor Count:

0

Hydrogen Bond Acceptor Count:

3

Rotatable Bond Count:

1

Heavy Atom Count:

23

Complexity:

450

  Synonyms
 loxapine

loxapine loxapine

loxapine

Cloxazepine

Oxilapine

1977-10-2

Loxitane

Loxapin

Dibenzacepin

Dibenzoazepine

Adasuve

Loxapina

Loxapinum

CL-62362

SUM 3170

Loxitane IM

HF3170

HF 3170

LW 3170

2-chloro-11-(4-methylpiperazin-1-yl)dibenzob,f1,4oxazepine

Dibenzb,f1,4oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-

S-805

SUM-3170

8-chloro-6-(4-methylpiperazin-1-yl)benzob1,4benzoxazepine

CHEMBL831

C18H18ClN3O

UNII-LER583670J

CHEBI:50841

LER583670J

Lossapina DCIT

Hydrofluoride 3170

CL 62,362

2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine

2-Chloro-11-(4-methyl-1-piperazinyl)dibenzb,f1,4oxazepine

Dibenz(b,f)(1,4)oxazepine, 2-chloro-11-(4-methyl-1-piperazinyl)-

Loxapinum INN-Latin

Loxapina INN-Spanish

CL-71563

Lossapina

Loxapine USAN:INN:BAN

AZ-004

Loxapine (USAN/INN)

CL 62362

S 805

Staccato loxapine

HSDB 3111

Loxapine (water)

Loxapine (DMSO)

Adasuve (TN)

EINECS 217-835-3

Loxitane Intramuscular

BRN 0626753

Spectrum_000355

2-Chloro-11-(4-methylpiperazino)dibenzo(b,f)(1,4)oxazepine

CL71,563

SpecPlus_000823

8-chloro-6-(4-methylpiperazin-1-yl)benzob1,5benzoxazepine

Prestwick0_000132

Prestwick1_000132

Prestwick2_000132

Prestwick3_000132

Spectrum2_001737

Spectrum3_001830

Spectrum5_001857

Loxitane-C Oral Suspension

Lopac0_000720

SCHEMBL94146

BSPBio_000204

BSPBio_003479

GTPL205

KBioSS_000835

DivK1c_006919

SPBio_001814

SPBio_002143

BPBio1_000226

DTXSID7023229

BDBM22871

KBio1_001863

KBio2_000835

KBio2_003403

KBio2_005971

KBio3_002983

3785AH

PDSP1_001058

PDSP2_001042

s5197

ZINC19796158

CCG-204805

CS-1105

DB00408

SDCCGSBI-0050698.P003

QTL1_000050

NCGC00021145-01

NCGC00021145-02

NCGC00021145-03

NCGC00021145-04

NCGC00021145-05

NCGC00021145-06

NCGC00021145-07

NCGC00021145-08

NCGC00021145-23

NCGC00022279-03

NCGC00022279-04

NCGC00022279-05

HY-17390

C07104

D02340

Q58614

AB00053735_15

AB00053735_16

977L102

L001085

BRD-K39915878-036-04-6

BRD-K39915878-036-05-3

BRD-K39915878-036-15-2

2-Chloro-11-(4-methylpiperazino)dibenzb,f1,4oxazepine

8-chloro-6-(4-methylpiperazino)benzob1,4benzoxazepine;succinic acid

13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo9.4.0.0^{3,8}pentadeca-1(11),3(8),4,6,9,12,14-heptaene

13-chloro-10-(4-methylpiperazin-1-yl)-2-oxa-9-azatricyclo9.4.0.0^{3,8}pentadeca-1(11),3,5,7,9,12,14-heptaene

  Experimental Data
 loxapine

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Drosophila melanogaster 20.000000000000000 umol/L 48.860000000000000 47.130000000000000 -3.536000000000000 NS FEMALES 33008901 Inactive
Drosophila melanogaster 200.000000000000000 umol/L 44.010000000000000 43.890000000000000 -0.279600000000000 NS MALES 33008901 Inactive
  Experimental Data Visualization
 loxapine

  Statistics Data
 loxapine

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Drosophila melanogaster -0.279600000000000 1 2
  Statistics Data Visualization
 loxapine